Cite
HARVARD Citation
Hansel, K. et al. (2022). Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32‐week real‐world experience during the COVID‐19 pandemic. Clinical and experimental dermatology. pp. 165-167. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hansel, K. et al. (2022). Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32‐week real‐world experience during the COVID‐19 pandemic. Clinical and experimental dermatology. pp. 165-167. [Online].